6-Hydroxynicotinic acid

Names

[ Name ]:
6-Hydroxynicotinic acid

[Synonym ]:
1,6-Dihydro-6-oxo-nicotinic acid
6-Hydroxynicotinic
6-hydroxypyridine-3-carboxylic acid
6-Hydroxy Nicotinic Acid
6-Hydroxynicotinic acid
5-Carboxy-2-pyridone
6-Hydroxyniacin
T6MVJ EVQ
2-hydroxy 5-carboxypyridine
1,6-dihydro-6-oxopyridine-3-carboxylic acid
3-Pyridinecarboxylic acid, 1,6-dihydro-6-oxo-
2-hydroxy 5-pyridine carboxylic acid
2-Hydroxy-5-pyridine
6-oxonicotinic acid
6-Oxo-1,6-dihydro-3-pyridinecarboxylic acid
MFCD00006277
1,6-Dihydro-6-oxo-3-pyridinecarboxylic acid
T6NJ BQ EVQ
5-carboxy-2-hydroxypyridine
6-Hydroxy-3-pyridinecarboxylic Acid
EINECS 225-682-9
2-Hydroxy-5-pyridinecarboxylic acid
6-Hydroxy-nicotinic acid

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
488.8±30.0 °C at 760 mmHg

[ Melting Point ]:
>300 °C(lit.)

[ Molecular Formula ]:
C₆H₅NO₃

[ Molecular Weight ]:
139.109

[ Flash Point ]:
249.4±24.6 °C

[ Exact Mass ]:
139.026947

[ PSA ]:
70.16000

[ LogP ]:
-0.96

[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C

[ Index of Refraction ]:
1.626

[ Storage condition ]:
Refrigerator

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi:Irritant

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2933399090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Customs

[ HS Code ]: 2933399090

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Nature 457(7231) , 910-4, (2009)

Multiple, complex molecular events characterize cancer development and progression. Deciphering the molecular networks that distinguish organ-confined disease from metastatic disease may lead to the i...

Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.

Kidney Int. 79(11) , 1244-53, (2011)

Autosomal dominant polycystic kidney disease (ADPKD) is a frequent cause of kidney failure; however, urinary biomarkers for the disease are lacking. In a step towards identifying such markers, we used...

Selenium and selenomethionine levels in prostate cancer patients.

Cancer Detect. Prev. 28(1) , 8-16, (2004)

Selenium (Se) and selenomethionine (Se-Met) have been identified as potential chemopreventive agents of prostate cancer. Using an assay for the speciation (separation and identification) and quantific...